Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06723626 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Vitamin C on Shock Duration and Microcirculation in Patients With Vasoplegia Syndrome After Cardiac Surgery

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoint(s) modified Show 8 more changesShow less
    • Primary completion date changed from estimate of Nov 30, 2025 to Aug 31, 2026
    • Trial completed
    • Interventions modified
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: 3 to 6
    • Study description shortened, about 44 words
    • Site details revised
    • Study title expanded, about 3 words
  2. Notable Primary endpoint revisedv2 Show 4 more changesShow less
    • Interventions: Placebo (Drug), ascorbic acid (Drug) to Hydrocortisone (Drug), Metabolic resuscitation agent (Drug)
    • Eligibility criteria expanded, about 22 words
    • Study description expanded, about 35 words
    • Study title shortened, about 1 word
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This pilot study intends to observe the effect of intravenous vitamin C on the prognosis and sublingual microcirculation in patients with vasoplegia syndrome after cardiac surgery through a prospective randomized controlled study method.
Trial Details
NCT Number NCT06723626
Lead Sponsor Southeast University, China
Conditions
(from sponsor)
Vasoplegia Syndrome
Related terms Vasoplegia
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov